Xiao Qun Wang
- Cancer Research top 5%
-
- Cardiovascular Function and Risk Factors 11
- Cardiovascular Disease and Adiposity 5
- Immunology top 10%
- Atherosclerosis and Cardiovascular Diseases 9
- Clinical Biochemistry top 5%
- Advanced Glycation End Products research 5
-
- Diabetes Treatment and Management 5
-
- Coronary Interventions and Diagnostics 9
-
- Cardiac Imaging and Diagnostics 5
-
- Adipokines, Inflammation, and Metabolic Diseases 5
Xiao Qun Wang
52 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 111
- Cancer Research 324
- Cardiology and Cardiovascular Medicine 353
- Immunology 259
- Clinical Biochemistry 83
- Endocrinology, Diabetes and Metabolism 145
Countries citing papers authored by Xiao Qun Wang
This map shows the geographic impact of Xiao Qun Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiao Qun Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiao Qun Wang more than expected).
Fields of papers citing papers by Xiao Qun Wang
This network shows the impact of papers produced by Xiao Qun Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiao Qun Wang. The network helps show where Xiao Qun Wang may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Xiao Qun Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 3 | |
| 3 | 2025 | 0 | |
| 4 | 2025 | 1 | |
| 5 | 2025 | 0 | |
| 6 | 2025 | 0 | |
| 7 | 2024 | 0 | |
| 8 | 2024 | 1 | |
| 9 | 2023 | 12 | |
| 10 | 2023 | 2 | |
| 11 | 2022 | 21 | |
| 12 | 2021 | 4 | |
| 13 | 2020 | 13 | |
| 14 | 2020 | 18 | |
| 15 | 2019 | 42 | |
| 16 | 2019 | 10 | |
| 17 | 2017 | 31 | |
| 18 | 2017 | 23 | |
| 19 | 2017 | 20 | |
| 20 | 2016 | 47 |
About Xiao Qun Wang
Xiao Qun Wang is a scholar working on Cardiology and Cardiovascular Medicine, Clinical Biochemistry, Immunology, Immunology and Allergy and Endocrinology, Diabetes and Metabolism, having authored 56 papers that have together received 1.4k indexed citations. Recurring topics across this work include Cardiovascular Function and Risk Factors (11 papers), Coronary Interventions and Diagnostics (9 papers), Atherosclerosis and Cardiovascular Diseases (9 papers), Cardiovascular Disease and Adiposity (5 papers), Cardiac Imaging and Diagnostics (5 papers), Adipokines, Inflammation, and Metabolic Diseases (5 papers), Diabetes Treatment and Management (5 papers) and Advanced Glycation End Products research (5 papers). The work is most often cited by research in Cancer Research (324 citations), Cardiology and Cardiovascular Medicine (353 citations), Immunology (259 citations), Clinical Biochemistry (83 citations) and Endocrinology, Diabetes and Metabolism (145 citations). Xiao Qun Wang has collaborated with scholars based in China, Italy and Japan. Frequent co-authors include Wei Feng Shen, Lin Lu, Ke Yang, Ruiyan Zhang, Ying Shen, Qiujing Chen, Yu He, Zhu Hui Liu, Jing Liu and Feng Ding. Their work appears in journals such as Cardiovascular Diabetology, International Journal of Cardiology, Journal of the American Heart Association, Atherosclerosis and European Heart Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.